From Cancer Manhattan Project to Quantum Oncotherapeutics and Nowadays Bioshield - The New Promise in Oncology

Quantum Oncotherapeutics

OncoDaily Party Berlin 2025

ESMO 2025

ESMO Announced the Ambassadors of 2025 Annual Meeting

ESMO Announced the Ambassadors of 2025 Annual Meeting

Where to study to become an ESMO President: 2025 Top Institutional Rankings

Where to study to become an ESMO President: 2025 Top Institutional Rankings

Benjamin Herzberg: The Impact of Eligibility Criteria on KRAS G12C Inhibitor Trials in NSCLC

Benjamin Herzberg: The Impact of Eligibility Criteria on KRAS G12C Inhibitor Trials in NSCLC

Vincent Rajkumar: We Need More New Classes of Myeloma Drugs

Vincent Rajkumar, Myeloma Drugs

10 Must-Read Posts in Immuno-Oncology This Week

Immuno-Oncology

100 Influential People in Oncology 2025 - Nominations are Open!

100 Influential People in Oncology 2025

CAPItello-291